Solara Active Pharma hits 13-yr high on U.S. FDA inspection success
** Shares of the pharma co SOLA.NS rise as much as 5.5% to
720 rupees, their highest since Dec. 1, 2006
** Co said on Saturday the U.S. FDA completed two successful
inspections at co's manufacturing facilities at Puducherry and
Mangalore, with zero 483 observations (https://bit.ly/3c4X27u)
** About 111,000 shares change hands, 1.7x 30-day avg
** SOLA shares have risen 57% this year as of last close
(Reporting by Nallur Sethuraman in Bengaluru)
((Sethuraman.NR@thomsonreuters.com; (+91 8061822737); Reuters
Messaging: nallur.sethuraman.thomsonreuters.com@reuters.net))
Recent news on Solara Active Pharma Sciences
See all newsIndia's Solara Active Pharma Sciences rises after quarterly profit
Brief: Solara Active Pharma Sciences Says Sept-Quarter Consol Net Profit 284.6 Million Rupees
Brief: Solara Active Pharma Sciences Says Tax Demand Of 1.62 Billion Rupees Reduced To Nil After Rectification
Brief: Solara Active Pharma Sciences June-Quarter Consol Net Profit 163.1 Million Rupees
Brief: Solara Active Pharma Sciences March-Quarter Consol Net Profit 96 Million Rupees